Abstract: Disclosed herein are an apparatus and method for providing a remote work environment. The apparatus includes one or more processors and executable memory for storing at least one program executed by the one or more processors. The at least one program performs Virtual Private Network (VPN) authentication in response to a request for remote access to a work network from a user terminal, performs user authentication in order to connect the user terminal that succeeds in VPN authentication to the work network, decrypts the encrypted user data area of the user terminal that is connected to the work network, and provides the remote work environment to the user terminal based on the user data area through the work network.

Abstract: A combined power plant is provided. The combined power plant includes a gas turbine configured to combust fuel to generate a rotating force, a boiler configured to heat water to generate steam, an ammonia decomposition apparatus configured to receive a combustion gas generated in the gas turbine to thermally decompose ammonia to generate a decomposed gas containing hydrogen, nitrogen, and a residual ammonia, a steam turbine configured to generate a rotating force using the steam generated in the boiler, and a decomposed gas supply line configured to supply the decomposed gas generated in the ammonia decomposition apparatus to a combustor of the gas turbine.

Abstract: A display panel includes a substrate having a first area in which first pixels are disposed and a second area in which second pixels and a light-transmitting area disposed between the second pixels are disposed, and a polarizing plate disposed above the light-transmitting area and including a light-transmitting pattern having a light transmittance higher than that of the remaining area, wherein the substrate includes a high-transmission area having a higher light transmittance than the remaining portion in a position corresponding to the second area.

Abstract: A complementary thin film transistor (TFT) includes a substrate and a first TFT and a second TFT disposed on the substrate, wherein a first conductive semiconductor layer of the first TFT and a second gate electrode layer of the second TFT are disposed in the same layer and include the same material.

Abstract: An artificial intelligence (AI) system capable of simulating functions of a human brain, such as recognition and judgment, by using the machine learning algorithm such as deep learning, and an application thereof are provided. A method of learning multi-modal data according to the AI system and an application thereof includes: obtaining first context information representing a characteristic of a first signal and second context information representing a characteristic of a second signal by using a first learning network model; obtaining hidden layer information based on the first context information and the second context information by using a second learning network model; obtaining a correlation value representing a relation degree between the hidden layer information by using the second learning network model; and learning the hidden layer information in which the correlation value is derived as a maximum value.

Abstract: The present invention relates to an orally-administered gene carrier and a use thereof, and more specifically, to: an oral gene carrier comprising, at the C-terminus of an immunoglobulin Fc region, a linker formed from cationic arginine and enabling the condensation of an anionic gene; and an oral composition for preventing, ameliorating or treating metabolic diseases, the composition comprising the gene carrier and the GLP-1 gene as active ingredients. The gene carrier, according to the present invention, may be usefully employed as an orally-administered carrier for various genes, and especially, is expected to be usable for preventing, ameliorating or treating metabolic diseases, such as diabetes and obesity, by effectively transferring the GLP-1 gene.

Abstract: The present invention relates to a nanoparticle for oral gene delivery, which is a novel oral gene delivery system capable of regulating blood glucose levels in biological systems and insulin secretion in response to ingested meals. More specifically, the present invention relates to a nanoparticle for gene delivery, comprising: an ionic polymer conjugated with bile acid or a bile acid derivative; and a gene; and to a pharmaceutical composition comprising the same.

Abstract: An artificial intelligence (AI) system capable of simulating functions of a human brain, such as recognition and judgment, by using the machine learning algorithm such as deep learning, and an application thereof are provided. A method of learning multi-modal data according to the AI system and an application thereof includes: obtaining first context information representing a characteristic of a first signal and second context information representing a characteristic of a second signal by using a first learning network model; obtaining hidden layer information based on the first context information and the second context information by using a second learning network model; obtaining a correlation value representing a relation degree between the hidden layer information by using the second learning network model; and learning the hidden layer information in which the correlation value is derived as a maximum value.

Abstract: The present invention relates to an orally-administered gene carrier, and more specifically, to an orally-administered gene carrier having cationic protamine connected to an immunoglobulin Fc region by an SMCC linker, the cationic protamine enabling the condensation of an anionic gene. The orally-administered gene carrier enables protamine, which is a protein having cationic properties, to bind to an Fc region and be condensed with a gene having anionic properties, and thus may effectively induce the in vivo expression of the gene, and when orally administered, may enable the gene to be transferred to the small intestine by protecting the gene from a degradation reaction resulting from an immune action of white blood cells and stomach acid, and may enable the half-life of the gene to be relatively long when the gene is expressed in the small intestine, and thus a potential for a long-term treatment effect has been confirmed.

Abstract: The present invention relates to an orally-administered gene carrier and a use thereof, and more specifically, to: an oral gene carrier comprising, at the C-terminus of an immunoglobulin Fc region, a linker formed from cationic arginine and enabling the condensation of an anionic gene; and an oral composition for preventing, ameliorating or treating metabolic diseases, the composition comprising the gene carrier and the GLP-1 gene as active ingredients. The gene carrier, according to the present invention, may be usefully employed as an orally-administered carrier for various genes, and especially, is expected to be usable for preventing, ameliorating or treating metabolic diseases, such as diabetes and obesity, by effectively transferring the GLP-1 gene.

Abstract: The present invention relates to a nanoparticle for oral gene delivery, which is a novel oral gene delivery system capable of regulating blood glucose levels in biological systems and insulin secretion in response to ingested meals. More specifically, the present invention relates to a nanoparticle for gene delivery, comprising: an ionic polymer conjugated with bile acid or a bile acid derivative; and a gene; and to a pharmaceutical composition comprising the same.